ATE192331T1 - Abgabesystem für impfstoffe und lagerstabile vorstufenlösung zur nachträglichen verkapselung von aktivstoffen - Google Patents
Abgabesystem für impfstoffe und lagerstabile vorstufenlösung zur nachträglichen verkapselung von aktivstoffenInfo
- Publication number
- ATE192331T1 ATE192331T1 AT94909807T AT94909807T ATE192331T1 AT E192331 T1 ATE192331 T1 AT E192331T1 AT 94909807 T AT94909807 T AT 94909807T AT 94909807 T AT94909807 T AT 94909807T AT E192331 T1 ATE192331 T1 AT E192331T1
- Authority
- AT
- Austria
- Prior art keywords
- storage
- delivery system
- pct
- active ingredients
- encapsulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2397193A | 1993-02-26 | 1993-02-26 | |
PCT/US1994/002053 WO1994018950A1 (en) | 1993-02-26 | 1994-02-25 | Vaccine delivery system and shelf-stable precursor solution for remote encapsulation of active ingredients |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE192331T1 true ATE192331T1 (de) | 2000-05-15 |
Family
ID=21818176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94909807T ATE192331T1 (de) | 1993-02-26 | 1994-02-25 | Abgabesystem für impfstoffe und lagerstabile vorstufenlösung zur nachträglichen verkapselung von aktivstoffen |
Country Status (13)
Country | Link |
---|---|
US (1) | US5879703A (de) |
EP (1) | EP0688206B1 (de) |
JP (1) | JPH08507077A (de) |
AT (1) | ATE192331T1 (de) |
AU (1) | AU677826B2 (de) |
CA (1) | CA2157125A1 (de) |
DE (1) | DE69424279T2 (de) |
DK (1) | DK0688206T3 (de) |
ES (1) | ES2145132T3 (de) |
HK (1) | HK1012991A1 (de) |
PT (1) | PT688206E (de) |
SG (1) | SG44911A1 (de) |
WO (1) | WO1994018950A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5629020A (en) * | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
EP1754488A1 (de) | 1999-05-24 | 2007-02-21 | Introgen Therapeutics, Inc. | Verfahren und Zusammensetzungen für nichtvirale Gentherapie zur Behandlung von hyperproliferativen Krankheiten |
US10293056B1 (en) | 2000-05-24 | 2019-05-21 | Board Of Regents, The University Of Texas System | Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
US6984395B2 (en) * | 2001-04-11 | 2006-01-10 | Qlt, Inc. | Drug delivery system for hydrophobic drugs |
US20060073530A1 (en) * | 2001-08-15 | 2006-04-06 | Olaf Schneewind | Methods and compositions involving sortase B |
US8597678B2 (en) * | 2005-12-30 | 2013-12-03 | Dermazone Solutions, Inc. | Nanolipidic particles |
US20140271782A1 (en) | 2013-03-15 | 2014-09-18 | Dermazone Solutions, Inc. | Method for preparing nanolipids with encapsulated alcohol |
WO2007092944A2 (en) * | 2006-02-08 | 2007-08-16 | Introgen Therapeutics, Inc. | Compositions and methods involving gene therapy and proteasome modulation |
US20140335166A1 (en) * | 2013-05-08 | 2014-11-13 | Michael W. Fountain | Methods of Making and Using Nano Scale Particles |
MX2010008168A (es) | 2008-01-25 | 2011-02-24 | P53 Inc | Biomarcadores p53. |
US9445975B2 (en) * | 2008-10-03 | 2016-09-20 | Access Business Group International, Llc | Composition and method for preparing stable unilamellar liposomal suspension |
CN102482666B (zh) | 2009-07-06 | 2017-02-08 | 变异生物技术公司 | 制备囊泡的方法和由其产生的制剂 |
US9907746B2 (en) | 2009-07-06 | 2018-03-06 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
JP6119030B2 (ja) | 2010-07-06 | 2017-04-26 | ヴァリエーション バイオテクノロジーズ インコーポレイテッド | インフルエンザを治療するための組成物及び方法 |
CN103533923A (zh) * | 2011-01-13 | 2014-01-22 | 变异生物技术公司 | 囊泡及由其产生之制剂的制备方法 |
CN103501811B (zh) | 2011-01-13 | 2016-03-30 | 变异生物技术公司 | 用于治疗病毒感染的组合物和方法 |
US9333675B2 (en) * | 2012-01-10 | 2016-05-10 | Hzo, Inc. | Profiles for precursors to polymeric materials |
CN104302323A (zh) | 2012-01-12 | 2015-01-21 | 变异生物技术公司 | 用于治疗病毒感染的组合物和方法 |
EP4008354A1 (de) | 2012-01-27 | 2022-06-08 | Variation Biotechnologies Inc. | Verfahren und zusammensetzungen für therapeutika |
EP3283045B1 (de) * | 2015-04-13 | 2021-02-17 | Fountain Technologies International, LLC | Einstufiges verfahren zur herstellung von ultrakleinen lipidstrukturen |
US20200078427A1 (en) | 2018-09-06 | 2020-03-12 | NuVessl, Inc. | Cannabis Sativa Derived Formulation for Transmucosal and Transdermal Delivery |
US11458092B2 (en) | 2018-12-14 | 2022-10-04 | NuVessl, Inc. | Composition with enhanced passenger molecule loading |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1695599A (en) * | 1927-05-24 | 1928-12-18 | Edward L Merzoian | Dispenser |
US2261877A (en) * | 1940-05-15 | 1941-11-04 | John G Erickson | Dispensing device |
US2712400A (en) * | 1952-04-28 | 1955-07-05 | Wayne C Stauffer | Dispensing means for paste tubes |
US3780911A (en) * | 1972-01-03 | 1973-12-25 | D Paige | Dispensing apparatus for collapsible tube container |
AU549154B2 (en) * | 1982-12-07 | 1986-01-16 | Motion, J.A.C. | Collapsible tube expressor |
US4588578A (en) * | 1983-08-08 | 1986-05-13 | The Liposome Company, Inc. | Lipid vesicles prepared in a monophase |
US4755375A (en) * | 1984-01-27 | 1988-07-05 | Associated Universities, Inc. | Method and kit for the selective labeling of red blood cells in whole blood with TC-99M |
US4610868A (en) * | 1984-03-20 | 1986-09-09 | The Liposome Company, Inc. | Lipid matrix carriers for use in drug delivery systems |
DK166762B1 (da) * | 1986-01-14 | 1993-07-12 | Nederlanden Staat | Fremgangsmaade til fremstilling af immunogenkomplekser og farmaceutisk sammensaetning indeholdende saadanne komplekser |
US5049388A (en) * | 1986-11-06 | 1991-09-17 | Research Development Foundation | Small particle aerosol liposome and liposome-drug combinations for medical use |
US5133965A (en) * | 1988-06-08 | 1992-07-28 | Fountain Pharmaceuticals, Inc. | Dressing material having adsorbed thereon a solvent dilution microcarrier precursor solution |
US5269979A (en) * | 1988-06-08 | 1993-12-14 | Fountain Pharmaceuticals, Inc. | Method for making solvent dilution microcarriers |
IL90561A (en) * | 1988-06-08 | 1993-08-18 | Fountain Pharm Inc | Method for making solvent dilution microcarriers |
NZ230424A (en) * | 1988-08-25 | 1992-05-26 | Liposome Co Inc | Liposomal composition comprising an externally disposed antigen |
US5100662A (en) * | 1989-08-23 | 1992-03-31 | The Liposome Company, Inc. | Steroidal liposomes exhibiting enhanced stability |
DE4136553A1 (de) * | 1991-11-06 | 1993-05-13 | Biotechnolog Forschung Gmbh | Impfstoff gegen schleimhauterreger und herstellungsverfahren |
-
1994
- 1994-02-25 DE DE69424279T patent/DE69424279T2/de not_active Expired - Fee Related
- 1994-02-25 CA CA002157125A patent/CA2157125A1/en not_active Abandoned
- 1994-02-25 PT PT94909807T patent/PT688206E/pt unknown
- 1994-02-25 JP JP6519296A patent/JPH08507077A/ja not_active Ceased
- 1994-02-25 WO PCT/US1994/002053 patent/WO1994018950A1/en active IP Right Grant
- 1994-02-25 AU AU62506/94A patent/AU677826B2/en not_active Ceased
- 1994-02-25 SG SG1996009249A patent/SG44911A1/en unknown
- 1994-02-25 ES ES94909807T patent/ES2145132T3/es not_active Expired - Lifetime
- 1994-02-25 DK DK94909807T patent/DK0688206T3/da active
- 1994-02-25 US US08/507,401 patent/US5879703A/en not_active Expired - Lifetime
- 1994-02-25 EP EP94909807A patent/EP0688206B1/de not_active Expired - Lifetime
- 1994-02-25 AT AT94909807T patent/ATE192331T1/de not_active IP Right Cessation
-
1998
- 1998-12-21 HK HK98114197A patent/HK1012991A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU6250694A (en) | 1994-09-14 |
DE69424279D1 (de) | 2000-06-08 |
EP0688206A1 (de) | 1995-12-27 |
EP0688206B1 (de) | 2000-05-03 |
WO1994018950A1 (en) | 1994-09-01 |
US5879703A (en) | 1999-03-09 |
PT688206E (pt) | 2000-08-31 |
CA2157125A1 (en) | 1994-09-01 |
AU677826B2 (en) | 1997-05-08 |
HK1012991A1 (en) | 1999-08-13 |
DK0688206T3 (da) | 2000-09-25 |
SG44911A1 (en) | 1997-12-19 |
JPH08507077A (ja) | 1996-07-30 |
ES2145132T3 (es) | 2000-07-01 |
DE69424279T2 (de) | 2000-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE192331T1 (de) | Abgabesystem für impfstoffe und lagerstabile vorstufenlösung zur nachträglichen verkapselung von aktivstoffen | |
IL112112A0 (en) | Peptide derivatives and pharmaceutical compositions containing them | |
IS4057A (is) | Efni til að auka kyngetu | |
YU47899B (sh) | Postupak za dobivanje preparata koji sprečava prenošenje polnih bolesti i tampona koji ga sadrži | |
ES2007720A6 (es) | Procedimiento de obtencion de una vacuna a base de flagelo bacterial. | |
HUP0100928A2 (hu) | Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
MY113488A (en) | Compounds with growth hormone releasing properties | |
TR200000649T2 (tr) | PTHrP analogları kullanılarak kırıkların iyileştirilmesi. | |
CA2224724A1 (en) | Subunit vaccine against flavivirus infection | |
AR020102A1 (es) | Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento | |
HUP0301349A2 (hu) | IL-11-tartalmú készítmények | |
SE8008415L (sv) | Cyklisk analog for fagocytosstimulerande naturpeptid, dvs treonyl-cyklo-(-n-lysyl-prolyl-arginyl-) | |
FI98510B (fi) | Vateriitti ja menetelmä sen valmistamiseksi | |
SE9101838D0 (sv) | Novel peptides and their use | |
FR2688499B1 (fr) | Procede de preparation de la beta-phenylisoserine et de ses analogues. | |
IT1244886B (it) | Dicarbonati e uretani dell'acido 4,5-diidrossi- e 4,5,8-triidrossi- 9,10-diidro-9,10-diosso-2-antracencarbossilico ad azione terapeutica | |
IT1228925B (it) | Procedimento per la preparazione dell'ormone della crescita umano | |
FI971127A (fi) | 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollageenin kypsymis- ja rakentumishäiriöiden hoitamiseen | |
EP0282501A1 (de) | Regulierung der tierreproduktion | |
IL86675A (en) | Immunogen containing non- infectious hiv particles and pharmaceutical compositions containing the same | |
DE69324345D1 (de) | Expression von osteogenem faktor op-1 in mit rekombinantem baculovirus infizierten spodoptera frugiperda-zellen | |
DK0811067T3 (da) | Equin arteritisviruspeptider, antistoffer og deres anvendelse i en diagnostisk test | |
JPS649938A (en) | Oral ingestive composition | |
ATE99955T1 (de) | Als anti-malaria-impfstoff verwendbares immunologisch aktives peptidkonjugat ppd-(nanp)n. | |
SE9901634D0 (sv) | Treatment of myocardial infarction with a substance related to the growth hormone axis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |